 | • レポートコード：GIR-2104Z07445 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メシル酸イマチニブ薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メシル酸イマチニブ薬の種類別市場規模（100mg、400mg）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メシル酸イマチニブ薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100mg、400mg ・用途別分析2016年-2026年：病院、薬局 ・メシル酸イマチニブ薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メシル酸イマチニブ薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メシル酸イマチニブ薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メシル酸イマチニブ薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メシル酸イマチニブ薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Imatinib Mesylate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Imatinib Mesylate Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Imatinib Mesylate Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Imatinib Mesylate Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg
400mg
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Imatinib Mesylate Drugs market are listed below:
Novartis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Imatinib Mesylate Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Mesylate Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg
1.2.3 400mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Mesylate Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Imatinib Mesylate Drugs Market Size & Forecast
1.4.1 Global Imatinib Mesylate Drugs Sales in Value (2016-2026))
1.4.2 Global Imatinib Mesylate Drugs Sales in Volume (2016-2026)
1.4.3 Global Imatinib Mesylate Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Imatinib Mesylate Drugs Production Capacity Analysis
1.5.1 Global Imatinib Mesylate Drugs Total Production Capacity (2016-2026)
1.5.2 Global Imatinib Mesylate Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imatinib Mesylate Drugs Market Drivers
1.6.2 Imatinib Mesylate Drugs Market Restraints
1.6.3 Imatinib Mesylate Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Imatinib Mesylate Drugs Product and Services
2.1.4 Novartis Imatinib Mesylate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Imatinib Mesylate Drugs Sales by Manufacturer
3.1 Global Imatinib Mesylate Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Imatinib Mesylate Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Imatinib Mesylate Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Imatinib Mesylate Drugs Manufacturer Market Share
3.4.2 Top 6 Imatinib Mesylate Drugs Manufacturer Market Share
3.5 Global Imatinib Mesylate Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Imatinib Mesylate Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imatinib Mesylate Drugs Market Size by Region
4.1.1 Global Imatinib Mesylate Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Imatinib Mesylate Drugs Revenue by Region (2016-2026)
4.2 North America Imatinib Mesylate Drugs Revenue (2016-2026)
4.3 Europe Imatinib Mesylate Drugs Revenue (2016-2026)
4.4 Asia-Pacific Imatinib Mesylate Drugs Revenue (2016-2026)
4.5 South America Imatinib Mesylate Drugs Revenue (2016-2026)
4.6 Middle East and Africa Imatinib Mesylate Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Imatinib Mesylate Drugs Sales in Volume by Type (2016-2026)
5.2 Global Imatinib Mesylate Drugs Revenue by Type (2016-2026)
5.3 Global Imatinib Mesylate Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Imatinib Mesylate Drugs Sales in Volume by Application (2016-2026)
6.2 Global Imatinib Mesylate Drugs Revenue by Application (2016-2026)
6.3 Global Imatinib Mesylate Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Imatinib Mesylate Drugs Sales by Type (2016-2026)
7.2 North America Imatinib Mesylate Drugs Sales by Application (2016-2026)
7.3 North America Imatinib Mesylate Drugs Market Size by Country
7.3.1 North America Imatinib Mesylate Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Imatinib Mesylate Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Imatinib Mesylate Drugs Sales by Type (2016-2026)
8.2 Europe Imatinib Mesylate Drugs Sales by Application (2016-2026)
8.3 Europe Imatinib Mesylate Drugs Market Size by Country
8.3.1 Europe Imatinib Mesylate Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Imatinib Mesylate Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Imatinib Mesylate Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Imatinib Mesylate Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Imatinib Mesylate Drugs Market Size by Region
9.3.1 Asia-Pacific Imatinib Mesylate Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Imatinib Mesylate Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Imatinib Mesylate Drugs Sales by Type (2016-2026)
10.2 South America Imatinib Mesylate Drugs Sales by Application (2016-2026)
10.3 South America Imatinib Mesylate Drugs Market Size by Country
10.3.1 South America Imatinib Mesylate Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Imatinib Mesylate Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imatinib Mesylate Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Imatinib Mesylate Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Imatinib Mesylate Drugs Market Size by Country
11.3.1 Middle East & Africa Imatinib Mesylate Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Imatinib Mesylate Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Imatinib Mesylate Drugs Typical Distributors
12.3 Imatinib Mesylate Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Imatinib Mesylate Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Imatinib Mesylate Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Imatinib Mesylate Drugs Product and Services
Table 6. Novartis Imatinib Mesylate Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Imatinib Mesylate Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Imatinib Mesylate Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Imatinib Mesylate Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Imatinib Mesylate Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Imatinib Mesylate Drugs Production Site of Key Manufacturer
Table 12. Global Imatinib Mesylate Drugs Sales by Region (2016-2021e) & (K Units)
Table 13. Global Imatinib Mesylate Drugs Sales by Region (2021-2026) & (K Units)
Table 14. Global Imatinib Mesylate Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Imatinib Mesylate Drugs Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 17. Global Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 18. Global Imatinib Mesylate Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Imatinib Mesylate Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 21. Global Imatinib Mesylate Drugs Price by Type (2021-2026) & (USD/Unit)
Table 22. Global Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 23. Global Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 24. Global Imatinib Mesylate Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Imatinib Mesylate Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 27. Global Imatinib Mesylate Drugs Price by Application (2021-2026) & (USD/Unit)
Table 28. North America Imatinib Mesylate Drugs Sales by Country (2016-2021e) & (K Units)
Table 29. North America Imatinib Mesylate Drugs Sales by Country (2021-2026) & (K Units)
Table 30. North America Imatinib Mesylate Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Imatinib Mesylate Drugs Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 33. North America Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 34. North America Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 35. North America Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 36. Europe Imatinib Mesylate Drugs Sales by Country (2016-2021e) & (K Units)
Table 37. Europe Imatinib Mesylate Drugs Sales by Country (2021-2026) & (K Units)
Table 38. Europe Imatinib Mesylate Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Imatinib Mesylate Drugs Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 41. Europe Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 42. Europe Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 43. Europe Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Asia-Pacific Imatinib Mesylate Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Asia-Pacific Imatinib Mesylate Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Asia-Pacific Imatinib Mesylate Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Imatinib Mesylate Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Asia-Pacific Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Asia-Pacific Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. Asia-Pacific Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 52. South America Imatinib Mesylate Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. South America Imatinib Mesylate Drugs Sales by Country (2021-2026) & (K Units)
Table 54. South America Imatinib Mesylate Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Imatinib Mesylate Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. South America Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 58. South America Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. South America Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Middle East & Africa Imatinib Mesylate Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. Middle East & Africa Imatinib Mesylate Drugs Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Imatinib Mesylate Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Imatinib Mesylate Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Imatinib Mesylate Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Middle East & Africa Imatinib Mesylate Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Imatinib Mesylate Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Middle East & Africa Imatinib Mesylate Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Imatinib Mesylate Drugs Typical Distributors
Table 71. Imatinib Mesylate Drugs Typical Customers
List of Figures
Figure 1. Imatinib Mesylate Drugs Picture
Figure 2. Global Imatinib Mesylate Drugs Sales Market Share by Type in 2020
Figure 3. 100mg
Figure 4. 400mg
Figure 5. Global Imatinib Mesylate Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Imatinib Mesylate Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Imatinib Mesylate Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Imatinib Mesylate Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Imatinib Mesylate Drugs Sales (2016-2026) & (K Units)
Figure 30. Global Imatinib Mesylate Drugs Production Capacity (2016-2026) & (K Units)
Figure 31. Global Imatinib Mesylate Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Imatinib Mesylate Drugs Market Drivers
Figure 33. Imatinib Mesylate Drugs Market Restraints
Figure 34. Imatinib Mesylate Drugs Market Trends
Figure 35. Global Imatinib Mesylate Drugs Sales Market Share by Manufacturer in 2020
Figure 36. Global Imatinib Mesylate Drugs Revenue Market Share by Manufacturer in 2020
Figure 37. Imatinib Mesylate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Imatinib Mesylate Drugs Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Imatinib Mesylate Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Imatinib Mesylate Drugs Sales Market Share by Region (2016-2026)
Figure 41. Global Imatinib Mesylate Drugs Revenue Market Share by Region (2016-2026)
Figure 42. North America Imatinib Mesylate Drugs Revenue (2016-2026) & (USD Million)
Figure 43. Europe Imatinib Mesylate Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Imatinib Mesylate Drugs Revenue (2016-2026) & (USD Million)
Figure 45. South America Imatinib Mesylate Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Imatinib Mesylate Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Global Imatinib Mesylate Drugs Sales Market Share by Type (2016-2026)
Figure 48. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2016-2026)
Figure 49. Global Imatinib Mesylate Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 51. Global Imatinib Mesylate Drugs Revenue Market Share by Application (2016-2026)
Figure 52. Global Imatinib Mesylate Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Imatinib Mesylate Drugs Sales Market Share by Country (2016-2026)
Figure 54. North America Imatinib Mesylate Drugs Revenue Market Share by Country (2016-2026)
Figure 55. North America Imatinib Mesylate Drugs Sales Market Share by Type (2016-2026)
Figure 56. North America Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 57. Europe Imatinib Mesylate Drugs Sales Market Share by Country (2016-2026)
Figure 58. Europe Imatinib Mesylate Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Europe Imatinib Mesylate Drugs Sales Market Share by Type (2016-2026)
Figure 60. Europe Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Imatinib Mesylate Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Imatinib Mesylate Drugs Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Imatinib Mesylate Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Imatinib Mesylate Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Imatinib Mesylate Drugs Revenue Market Share by Country (2016-2026)
Figure 67. South America Imatinib Mesylate Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Imatinib Mesylate Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のメシル酸イマチニブ市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 世界のメシル酸ベンズトロピン市場 2021：企業別、地域別、種類・用途別 The Benztropine Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のイマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界のドキサゾシンメシレート市場 2021：企業別、地域別、種類・用途別 The Doxazosin Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のペグアスパラガーゼ薬市場 2021：企業別、地域別、種類・用途別 The Pegaspargase Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…